At the time of writing, Milestone Pharmaceuticals Inc [MIST] stock is trading at $1.59, up 7.43%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The MIST shares have gain 11.19% over the last week, with a monthly amount glided 4.61%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Milestone Pharmaceuticals Inc [NASDAQ: MIST] stock has seen the most recent analyst activity on August 22, 2024, when Rodman & Renshaw initiated its Buy rating and assigned the stock a price target of $9. Previously, Jefferies downgraded its rating to Hold on June 20, 2023, and dropped its price target to $4. On April 22, 2022, upgrade upgraded it’s rating to Overweight and revised its price target to $10 on the stock. H.C. Wainwright started tracking the stock assigning a Buy rating and suggested a price target of $20 on March 05, 2021. Oppenheimer upgraded its rating to a Outperform but $18 remained the price target by the analyst firm on July 29, 2020. Jefferies upgraded its rating to Buy for this stock on July 24, 2020. In a note dated March 25, 2020, Jefferies downgraded an Hold rating on this stock and revised its target price from $28 to $3.
For the past year, the stock price of Milestone Pharmaceuticals Inc fluctuated between $1.12 and $3.52. Currently, Wall Street analysts expect the stock to reach $10 within the next 12 months. Milestone Pharmaceuticals Inc [NASDAQ: MIST] shares were valued at $1.59 at the most recent close of the market. An investor can expect a potential return of 528.93% based on the average MIST price forecast.
Analyzing the MIST fundamentals
Gross Profit Margin for this corporation currently stands at 1.7% with Operating Profit Margin at 57.03%, Pretax Profit Margin comes in at 56.01%, and Net Profit Margin reading is 55.77%. To continue investigating profitability, this company’s Return on Assets is posted at -0.54, Equity is -1.65 and Total Capital is -0.58. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.63.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.4900 points at the first support level, and at 1.3900 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.6700, and for the 2nd resistance point, it is at 1.7500.
Ratios To Look Out For
It is important to note that Milestone Pharmaceuticals Inc [NASDAQ:MIST] has a current ratio of 19.13. Further, the Quick Ratio stands at 19.13, while the Cash Ratio is 2.9.
